Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Publisher Information:
Elsevier Science 2022
- Abstract:
DEAR EDITOR, As of December 2021, more than 276 million affected cases and 5 million deaths were reported by the World Health Organization, due to the COVID-19 pandemic. Following the outbreak's beginning, patients receiving treatments impairing their immunity (e.g., chemotherapy; immunosuppressive drugs for solid organ transplantation or inflammatory diseases) were soon recognized as being at increased risk of developing severe forms of COVID-19. Although anti-SARS-CoV-2 vaccines have proven to be efficacious in reducing the risk of both severe disease and mortality in the general population, emerging evidence has revealed that immunocompromized patients actually display a reduction in vaccine-induced humoral responses. To our best knowledge, the impact of therapeutic plasma exchange (TPE) on anti-SARS-CoV-2 vaccines responses has not yet been investigated so far. [...]
- Subject Terms:
- Availability:
Open access content. Open access content
info:eu-repo/semantics/openAccess
- Note:
English
- Other Numbers:
UCDLC oai:dial.uclouvain.be:boreal:261408
boreal:261408
info:doi/10.1016/j.ejim.2022.02.014
info:pmid/35181184
urn:ISSN:0953-6205
urn:EISSN:1879-0828
1328222765
- Contributing Source:
UNIVERSITE CATHOLIQUE DE LOUVAIN
From OAIster®, provided by the OCLC Cooperative.
- Accession Number:
edsoai.on1328222765
HoldingsOnline
No Comments.